Silverback Male Enhancement
86/100
This product is generally safe
- Folic Acid: 400mg is 400.0× the Tolerable Upper Intake Level (1.0mg)
- Contains proprietary blend — exact ingredient amounts not disclosed
- 44% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Folic Acid: 400mg is 400.0× the Tolerable Upper Intake Level (1.0mg)
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed
Label Data
60 mL
Serving Size
Other Combinations
Product Type
44%
Evidence Coverage
Supplement Facts — Evidence Check
Calories
5 Calorie(s)
Total Carbohydrates
33 mg
(165% DV)
✅ 2.4× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
40 mg
(2000% DV)
📊 30.8× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
400 mg
(10% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 400.0× (UL: 1.0 mg)
📚 225 studies (Tier A: 10, B: 105)
500 mg
(8333% DV)
📊 208333.3× RDA — above typical dose
📚 138 studies (Tier A: 1, B: 44)
Sodium
5 mg
(1% DV)
Potassium
10 mg
(1% DV)
Proprietary Blend
2000 NP
Other Ingredients
Water, Filtered
Natural Flavors
Sucralose
Potassium Sorbate
Sodium Benzoate
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult Male (18-50 Years)
Product Information
📋 Directions for Use
Shake well
🧪 Formulation Notes
Maximum size No headache 100% Satisfaction guaranteed XXX Power
Additional Information
100% Strong man approved
Refrigerate after opening
Product Details
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Awake Energy Shot Grape
Market America
100
Rest Well Tasty Minty Flavour Spray
Higher Nature
100
5-Hour Energy Grape
Living Essentials
100
5-Hour Energy Grape
Living Essentials
100
Fuel 7 Hour Energy Shot Fruit Flavor
Advanced Healthcare Distributors
100